Teva Seeks Ban On Generic MS Drug Approvals By FDA

Teva Seeks Ban On Generic MS Drug Approvals By FDA

Teva Pharmaceutical Industries Ltd. urged a Washington, D.C., federal court on Thursday to bar the U.S. Food and Drug Administration from approving generic versions of its multiple sclerosis treatment Copaxone unless they meet more stringent clinical ...read more

  • Tags: